Skip to main content

Bruker Cellular Analysis, Inc.

CELLDelisted Oct 2, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001689657

Bruker Cellular Analysis, Inc. was delisted on Oct 2, 2023; its insiders filed their last Form 4 on Oct 3, 2023; 57 institutions reported holding it in 13F filings for Q3 2023, worth $35.8M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Bruker Cellular Analysis, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CELL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders10384−19
Shares54.6M45.0M−9.53M (−17.5%)
Value$63.3M$22.1M−$41.2M (−65.1%)

New holders (14)

Institutions that held Bruker Cellular Analysis, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CELL in Q2 2023
InstitutionSharesValue% of portfolio
Squarepoint Ops LLC200,912$98.4K0.00%
Y-Intercept (Hong Kong) Ltd186,544$91.4K0.01%
Old Mission Capital LLC121,640$59.6K0.00%
Cresset Asset Management, LLC112,581$55.2K0.00%
Two Sigma Investments, LP105,302$51.6K0.00%
Qube Research & Technologies Ltd99,718$48.9K0.00%
Jane Street Group, LLC45,827$22.5K0.00%
HRT Financial LP37,244$18.0K0.00%
State of Wyoming24,401$12.0K0.00%
Balyasny Asset Management LLC15,490$7.59K0.00%
Cubist Systematic Strategies, LLC15,172$7.43K0.00%
Crystalline Management Inc.12,092$5.92K0.00%
Point72 Middle East FZE3,855$1.89K0.00%
Point72 Asset Management, L.P.72$350.00%

Sold out (33)

Institutions that held Bruker Cellular Analysis, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.